# Bristol-Myers Squibb Company (BMY) — Q4-2015 Earnings Results

**Report date:** 2016-01-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2015

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 0.89%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.38 | N/A | +36.20% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on their product pipeline and market position. However, they did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in research and development.

> The team expressed confidence in future product pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a strong EPS performance, exceeding expectations significantly. However, the stock reacted negatively, declining by 0.89%, possibly due to the lack of revenue details and forward guidance. Investors may be cautious as they await more information on future performance and product developments.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2015_